Poultry Diseases Questions: Essential Knowledge on Bacterial and Viral Pathogens in Commercial Flocks

Introduction

Commercial poultry production faces constant pressure from infectious diseases, with bacterial pathogens representing a major cause of morbidity, mortality, and economic loss. Understanding the clinical presentation, necropsy findings, diagnostic approaches, and control strategies for these pathogens is essential for veterinary practitioners and flock managers. This article addresses frequently asked questions concerning the most clinically relevant bacterial diseases in chickens, turkeys, and other poultry species, with a focus on Mycoplasma gallisepticum, avian pathogenic Escherichia coli (APEC), and Pasteurella multocida. Brief consideration of viral differentials is included to support accurate diagnostic differentiation.

Mycoplasma gallisepticum

Etiology and Pathogenesis

Mycoplasma gallisepticum (MG) is a cell wall deficient bacterium of the class Mollicutes. Its lack of a peptidoglycan layer renders it intrinsically resistant to beta-lactam antimicrobials and confers a pleomorphic morphology (0.2 to 0.3 µm in diameter). MG colonizes the respiratory epithelium of chickens and turkeys, adhering via specialized adhesion proteins (e.g., GapA, CrmA) to sialic acid receptors on ciliated epithelial cells. This adherence disrupts mucociliary clearance, leading to secondary bacterial invasions. MG also exhibits the capacity for intracellular survival within non-phagocytic cells, contributing to chronic infection and immune evasion.

Clinical Signs and Necropsy Findings

Clinical signs in broilers and layers include nasal discharge, conjunctivitis, tracheal rales, snicking, and reduced feed intake. In turkeys, infraorbital sinus swelling is characteristic. Egg production drops by 10% to 40% in laying hens, and eggshell quality deteriorates (thin shells, roughened surfaces). Necropsy reveals catarrhal to mucopurulent tracheitis, airsacculitis (thickened, cloudy air sacs with caseous exudate), and sometimes peritonitis in severe cases. Histopathology shows lymphoid hyperplasia, epithelial hyperplasia, and mononuclear cell infiltration in the tracheal mucosa.

Diagnosis

Isolation of MG requires specialized media (e.g., Frey's medium supplemented with 15% swine serum and 0.01% NAD) and incubation under microaerophilic conditions (5% CO2 at 37°C) for 3 to 10 days. Colonies exhibit a characteristic "fried egg" appearance. Molecular detection via PCR targeting the mgc2 gene or 16S rRNA is more rapid and sensitive. Serological tests include rapid serum agglutination (RSA) and hemagglutination inhibition (HI). ELISA kits are available but may show cross-reactivity with Mycoplasma synoviae. Detailed discussion of serological principles can be found in the Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus article, though the antigen targets differ.

Control and Prevention

Biosecurity remains the cornerstone: all-in/all-out management, strict visitor protocols, and sourcing MG-free stock. Vaccination with live attenuated strains (e.g., ts-11, 6/85) or inactivated bacterins is used in layers and breeders. Antimicrobial therapy (e.g., tylosin, tilmicosin, enrofloxacin) reduces clinical signs but does not eliminate the organism. Eradication in breeder flocks involves serological surveillance, culling of positive birds, and antibiotic treatment of replacements.

Avian Pathogenic Escherichia coli (APEC)

Etiology and Pathogenesis

Avian pathogenic Escherichia coli (APEC) belongs to the extraintestinal pathogenic E. coli (ExPEC) pathotype and is a major cause of colibacillosis in poultry. Key virulence factors include F-type fimbriae (type 1 pili), P-fimbriae (Pap), aerobactin siderophores, hemolysins, and the virulence plasmid pAPEC-1 carrying iss (increased serum survival) and tsh (temperature-sensitive hemagglutinin) genes. APEC initially colonizes the upper respiratory tract following immunosuppression or viral damage (e.g., by infectious bronchitis virus or Newcastle disease virus). Subsequently, the bacteria invade the bloodstream via the air sacs, causing septicemia, polyserositis, and pericarditis. Detailed pathotyping and virulence mechanisms are covered in the Avian Pathogenic Escherichia coli (APEC): Virulence Factors, Rapid Diagnostic Assays, and Biosecurity Strategies article.

Clinical Signs and Necropsy Findings

In broilers, colibacillosis often manifests after week 2 with increased mortality, lameness (due to synovitis and osteomyelitis), and respiratory signs (dyspnea, gasping). Layers show peritonitis, salpingitis, and egg peritonitis (often with foul-smelling, coagulated yolk material). Necropsy findings in acute septicemic cases include:

• Pericarditis: thickened, opaque pericardium with fibrinopurulent exudate.
• Airsacculitis: clouded, thickened air sacs with caseous exudate.
• Perihepatitis: fibrinous deposition on the liver capsule (often described as "pepper and liver" appearance when combined with airsacculitis).
• Coligranuloma (Hjarre's disease): granulomatous lesions in liver, ceca, and duodenum (less common, associated with serotype O141).

Histopathology reveals fibrinonecrotic inflammation, bacterial emboli in capillaries, and heterophilic infiltration.

Diagnosis

Isolation on MacConkey agar yields pink colonies (lactose fermenters). Biochemical identification using commercial panels or MALDI-TOF mass spectrometry confirms E. coli. Serotyping (O antigens) is performed for epidemiological purposes but is not routinely done. Molecular pathotyping by PCR detection of iss, tsh, iucD, and papC genes distinguishes APEC from commensal strains. Antimicrobial susceptibility testing via broth microdilution or disk diffusion guides therapy.

Control and Prevention

Biosecurity (litter management, ventilation, water sanitization) reduces APEC exposure. Autogenous bacterins or recombinant vaccines targeting virulence factors (e.g., type 1 pili, aerobactin receptor) are used in problem flocks, though efficacy varies. Antimicrobial therapy faces challenges from multidrug resistance; fluoroquinolones, aminoglycosides, and tetracyclines should be based on sensitivity profiles. The article on Avian Colibacillosis: Diagnosis, Antimicrobial Resistance Trends, and Control Strategies in Poultry Flocks provides additional perspectives.

Pasteurella multocida (Avian Cholera)

Etiology and Pathogenesis

Pasteurella multocida is a Gram-negative coccobacillus responsible for fowl cholera, a highly contagious septicemic disease in waterfowl, turkeys, and chickens. Serotype A:1 and A:3 are most common in poultry; serotypes B and E occur in cattle. The capsule (hyaluronic acid) and lipopolysaccharide (LPS) contribute to serum resistance and phagocytosis evasion. Virulence factors include the toxin PMT (Pasteurella multocida toxin), which activates intracellular signaling via Gq/G11 proteins, leading to osteolysis and mitogenic effects in fibroblasts. In poultry, PMT is less critical than in swine.

Clinical Signs and Necropsy Findings

Peracute death without premonitory signs is frequent, especially in turkeys. Acute cases present with fever, anorexia, cyanosis of combs and wattles, mucoid diarrhea, and respiratory distress. Necropsy findings include:

• Petechial hemorrhages on epicardium, serosal surfaces, and abdominal fat.
• Splenomegaly: dark, friable spleen with military necrotic foci.
• Hepatic necrosis: multiple pale, pinpoint necrotic foci throughout the liver parenchyma.
• Pneumonia with fibrinous consolidation (less common in chickens, more in turkeys).
• Joint lesions (purulent arthritis) in chronic carriers.

Diagnosis

Gram stain of liver or spleen impression smears reveals bipolar staining (safety pin appearance) with Wright or Giemsa stain. Isolation on blood agar yields small, gray, mucoid colonies with sweetish odor; a satellite phenomenon may be observed with Staph streak. Biochemical identification (oxidase positive, indole positive) is confirmatory. Molecular detection uses PCR targeting the kmt1 gene. Serotyping via Heddleston's gel diffusion precipitin test identifies capsular types.

Control and Prevention

Inactivated bacterins (serogroup-specific) protect against homologous serotypes; autogenous vaccines are used when emerging serotypes cause outbreaks. Live attenuated vaccines (e.g., CU strain) are available but may cause transient clinical signs in naïve birds. Strict biosecurity and control of fomites (rodents, wild birds, contaminated equipment) are critical. Antimicrobial therapy with tetracyclines (oxytetracycline, chlortetracycline), sulfonamides, or penicillin should be initiated early. Refer to Avian Cholera in Waterfowl: Pasteurella multocida Serotypes, Outbreak Dynamics, and Vaccination Approaches in Wild and Domestic Birds for expanded discussion.

Other Clinically Important Bacterial Pathogens

Brief mention is warranted for other bacterial pathogens frequently encountered in poultry:

• Clostridium perfringens Type A and G: Causes necrotic enteritis in broilers, characterized by necrotic pseudomembrane lining the small intestine. Predisposing factors include coccidiosis (especially Eimeria acervulina and E. maxima) and high dietary protein. Diagnosis via anaerobic culture and PCR detection of netB and tpeL toxin genes. Control includes coccidiosis management, dietary enzyme supplements, and alternatives to in-feed antibiotics. See Necrotic Enteritis in Broiler Chickens: Clostridium perfringens Virulence Factors, Gut Microbiome, and Probiotic Control Strategies for full coverage.

• Salmonella enterica serovars (Enteritidis, Typhimurium, Heidelberg): Cause pullorum disease (S. Pullorum) and fowl typhoid (S. Gallinarum) in chickens; S. Enteritidis remains an egg safety concern. Diagnosis via selective enrichment (tetrathionate broth), plating on XLD or brilliant green agar, and serotyping using Kauffmann-White scheme. Control involves National Poultry Improvement Plan (NPIP) monitoring, vaccination (live and killed), and elimination of carriers. Zoonotic implications are discussed in Salmonella enterica Serovar Typhimurium in Backyard Poultry Flocks: Zoonotic Risk, Antimicrobial Resistance, and Biosecurity.

• Mycoplasma synoviae (MS): Causes synovitis, tendovaginitis, and respiratory disease. PCR targeting vlhA gene distinguishes MS from MG. Serological cross-reactivity with MG is problematic; confirm with HI or ELISA blocking.

• Ornithobacterium rhinotracheale (ORT): Associated with respiratory disease in turkeys and chickens, often coinfecting with MG or APEC. Isolation is fastidious (blood agar with 5% CO2). PCR is preferred. Sensitivity to antibiotics is variable; tetracyclines and gentamicin are commonly used.

• Riemerella anatipestifer: Causes epizootic septicemia in ducks and some other waterfowl. Necropsy reveals fibrinous pericarditis, perihepatitis, and meningitis with caseous exudate in air sacs. Isolation on blood agar or PPLO agar. Vaccination with bacterins is available for duck flocks.

• Erysipelothrix rhusiopathiae: Causes erysipelas in turkeys (less in chickens), presenting with sudden death, cyanotic skin lesions, and hemorrhagic myocarditis. Diagnosis via Gram stain (slender Gram-positive rods) and isolation on selective media. Penicillin is the treatment of choice.

Viral Differentials

Several viral infections produce clinical signs overlapping with bacterial diseases, requiring careful diagnostic differentiation. The following table compares key viral pathogens with bacterial mimics:

The article on Avian Influenza A(H5N1) in Poultry and Wild Birds: Current Epidemiology, Molecular Diagnostics, and Biosecurity provides extensive guidance for viral respiratory disease management.

Diagnostic Workflow

The following Mermaid diagram illustrates a simplified diagnostic decision tree for respiratory and septicemic presentations in poultry flocks:

flowchart TD
    A[Flock presenting with respiratory signs\nor acute mortality], > B{History & Clinical Exam}
    B, > C[Sudden death with\ncyanosis & gross lesions]
    C, > D[Perform necropsy & sample collection:\nLiver, spleen, trachea, lung, heart blood]
    D, > E[Gram stain of exudates\nand organ impressions]
    E, > F["Gram-negative bipolar rods?\n(Pasteurella multocida)"]
    F, > G[Culture on blood agar\n& McConkey agar]
    G, > H["P. multocida isolated\n(oxidase +, indole +)"]
    H, > I[Diagnosis: Avian Cholera]
    E, > J["Small Gram-negative coccobacilli?\n(MG or ORT)"]
    J, > K{Respiratory signs\nwith sinus swelling?}
    K, > L[Yes: Suspect MG,\nPCR for mgc2]
    K, > M[No: Suspect ORT,\nPCR for 16S ORT]
    E, > N["Gram-negative rods\n(lactose fermenter)?"]
    N, > O[E. coli isolation,\nPCR for APEC virulence genes]
    O, > P[Diagnosis: Colibacillosis]
    B, > Q[Neurologic signs\nor egg drop without resp?]
    Q, > R[Suspect viral origin:\nNDV, AIV, AE]
    R, > S[Molecular testing:\nMultiplex RT-PCR for NDV, AIV, IBV]

Biosecurity and Integrated Control

Control of bacterial pathogens in poultry requires a multifaceted approach. Key biological principles include:

1. Reservoir reduction: Healthy carrier birds shed bacteria intermittently. Cull positive breeders; depopulate contaminated houses.
2. Transmission interruption: All-in/all-out placement, disinfection of drinking water lines (chlorine dioxide, hydrogen peroxide), and footbaths with phenolic compounds. Rodent and wild bird exclusion prevents introduction of Salmonella and Pasteurella.
3. Host resistance enhancement: Vaccination against MG, APEC, and NDV reduces susceptibility. Nutritional factors (organic acids, probiotics, phytogenic feed additives) modulate gut microbiota and reduce Clostridium perfringens proliferation.
4. Antimicrobial stewardship: Culture-based sensitivity testing is essential. Empirical therapy should match known farm resistance patterns. Withdrawal times for egg production must be observed.

Conclusion

A methodical diagnostic approach integrating clinical assessment, necropsy, cytology, culture, and molecular methods enables accurate identification of bacterial pathogens in commercial poultry flocks. Mycoplasma gallisepticum, APEC, and Pasteurella multocida remain the most frequently diagnosed bacterial agents, but differentials including Clostridium perfringens, Salmonella, and viral pathogens must be considered. Control relies on rigorous biosecurity, strategic vaccination, and judicious antimicrobial use guided by susceptibility data. Continued surveillance for emerging serotypes and antimicrobial resistance trends is crucial for sustainable poultry production.

References

[1] Saif, Y.M., Fadly, A.M., Glisson, J.R., McDougald, L.R., Nolan, L.K., and Swayne, D.E. (Eds.). Diseases of Poultry. 13th edition. Wiley-Blackwell.

[2] Swayne, D.E., Glisson, J.R., McDougald, L.R., Nolan, L.K., Suarez, D.L., and Nair, V.L. (Eds.). Diseases of Poultry. 14th edition. Wiley-Blackwell.

[3] Jordan, F.T.W., and Pattison, M. (Eds.). Poultry Diseases. 5th edition. W.B. Saunders.

[4] Charlton, B.R., Bermudez, A.J., and Fulton, R.M. Avian Biosecurity and Health Management. American Association of Avian Pathologists.

[5] World Organisation for Animal Health. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 3.3.1: Avian Mycoplasmosis. Available online.

[6] Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals. 5th edition. CLSI supplement VET01.